Sumitomo Mitsui DS Asset Management’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$23.8M Buy
188,484
+4,938
+3% +$651K 0.16% 112
2026
Q1
$25.6M Buy
183,546
+2,784
+2% +$390K 0.21% 93
2025
Q4
$22.2M Buy
180,762
+7,120
+4% +$865K 0.17% 109
2025
Q3
$19.3M Buy
173,642
+2,294
+1% +$261K 0.16% 124
2025
Q2
$19M Buy
171,348
+3,730
+2% +$397K 0.17% 112
2025
Q1
$18.8M Buy
167,618
+7,925
+5% +$818K 0.19% 99
2024
Q4
$14.8M Buy
159,693
+7,295
+5% +$657K 0.15% 120
2024
Q3
$12.8M Sell
152,398
-11,741
-7% -$896K 0.14% 139
2024
Q2
$11.3M Buy
164,139
+12,518
+8% +$835K 0.13% 137
2024
Q1
$11.1M Buy
151,621
+5,465
+4% +$420K 0.14% 140
2023
Q4
$11.8M Buy
146,156
+2,261
+2% +$176K 0.15% 140
2023
Q3
$10.8M Buy
143,895
+4,271
+3% +$329K 0.17% 113
2023
Q2
$10.8M Buy
139,624
+25,010
+22% +$1.99M 0.16% 116
2023
Q1
$9.51M Buy
114,614
+4,963
+5% +$411K 0.17% 107
2022
Q4
$9.41M Sell
109,651
-9,534
-8% -$755K 0.19% 103
2022
Q3
$7.35M Buy
119,185
+6,570
+6% +$414K 0.17% 113
2022
Q2
$6.96M Buy
112,615
+5,371
+5% +$333K 0.17% 113
2022
Q1
$6.38M Buy
107,244
+3,563
+3% +$228K 0.14% 137
2021
Q4
$7.53M Buy
103,681
+2,770
+3% +$191K 0.16% 125
2021
Q3
$7.05M Sell
100,911
-29,128
-22% -$2.05M 0.17% 121
2021
Q2
$8.95M Buy
130,039
+1,153
+0.9% +$77K 0.21% 98
2021
Q1
$8.33M Buy
128,886
+5,732
+5% +$370K 0.22% 101
2020
Q4
$7.17M Sell
123,154
-1,163
-0.9% -$70.2K 0.2% 106
2020
Q3
$7.86M Buy
124,317
+2,987
+2% +$207K 0.25% 85
2020
Q2
$9.34M Sell
121,330
-7,645
-6% -$586K 0.32% 69
2020
Q1
$9.64M Sell
128,975
-7,531
-6% -$520K 0.4% 56
2019
Q4
$8.87M Sell
136,506
-647
-0.5% -$42.1K 0.3% 75
2019
Q3
$8.69M Buy
137,153
+20,773
+18% +$1.36M 0.32% 67
2019
Q2
$7.86M Sell
116,380
-21,132
-15% -$1.39M 0.32% 70
2019
Q1
$8.94M Buy
137,512
+11,284
+9% +$750K 0.15% 136
2018
Q4
$7.89M Sell
126,228
-3,911
-3% -$273K 0.14% 136
2018
Q3
$10M Buy
130,139
+38,633
+42% +$2.92M 0.15% 127
2018
Q2
$6.48M Buy
91,506
+760
+0.8% +$53.7K 0.1% 159
2018
Q1
$6.84M Sell
90,746
-3,588
-4% -$285K 0.1% 156
2017
Q4
$6.76M Sell
94,334
-5,539
-6% -$421K 0.1% 165
2017
Q3
$8.09M Sell
99,873
-3,708
-4% -$284K 0.13% 151
2017
Q2
$7.33M Sell
103,581
-5,642
-5% -$375K 0.12% 162
2017
Q1
$7.42M Buy
109,223
+9,654
+10% +$679K 0.13% 165
2016
Q4
$7.13M Sell
99,569
-4,347
-4% -$323K 0.14% 159
2016
Q3
$8.22M Sell
103,916
-29,339
-22% -$2.38M 0.18% 153
2016
Q2
$11.1M Sell
133,255
-17,712
-12% -$1.57M 0.34% 82
2016
Q1
$13.9M Sell
150,967
-4,268
-3% -$385K 0.43% 65
2015
Q4
$15.7M Buy
155,235
+1,234
+0.8% +$128K 0.53% 54
2015
Q3
$15.1M Sell
154,001
-8,983
-6% -$998K 0.52% 47
2015
Q2
$19.1M Sell
162,984
-8,373
-5% -$915K 0.6% 37
2015
Q1
$16.8M Sell
171,357
-28,565
-14% -$2.9M 0.51% 54
2014
Q4
$18.8M Sell
199,922
-18,133
-8% -$1.88M 0.58% 41
2014
Q3
$23.2M Sell
218,055
-33,210
-13% -$3.25M 0.71% 29
2014
Q2
$20.8M Sell
251,265
-40,233
-14% -$3.13M 0.59% 38
2014
Q1
$20.7M Buy
291,498
+6,449
+2% +$506K 0.61% 38
2013
Q4
$21.4M Sell
285,049
-42,104
-13% -$2.93M 0.62% 40
2013
Q3
$20.6M Sell
327,153
-14,762
-4% -$882K 0.59% 44
2013
Q2
$17.5M Buy
+341,915
New +$17.8M 0.49% 48

Other funds holding GILD

Sumitomo Mitsui DS Asset Management's GILD Position: Q2 2026 in Review

Sumitomo Mitsui DS Asset Management increased its Gilead Sciences (GILD) stake by 2.7% in Q2 2026, buying an estimated $651K and bringing the position to 188,484 shares worth $23.8M. The position accounts for 0.16% of the portfolio, ranked #112.

Sumitomo Mitsui DS Asset Management first reported a position in GILD in Q2 2013 and has held it in 53 quarters since. The position peaked at $25.6M in Q1 2026. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Sumitomo Mitsui DS Asset Management held 188,484 shares of Gilead Sciences worth $23.8M as of Q2 2026.
  • Sumitomo Mitsui DS Asset Management bought 4,938 Gilead Sciences shares in Q2 2026, an estimated $651K.
  • Gilead Sciences made up 0.16% of Sumitomo Mitsui DS Asset Management's portfolio in Q2 2026, its #112 holding.
  • Sumitomo Mitsui DS Asset Management first reported a position in Gilead Sciences in Q2 2013 and has held it in 53 quarters since.
  • Sumitomo Mitsui DS Asset Management's Gilead Sciences position peaked at $25.6M in Q1 2026.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Sumitomo Mitsui DS Asset Management's 13F filing for Q2 2026, filed 22 Jul 2026.